AI Chatbot Performance in Orthopedic Education: GPT-4o Outperforms AAOS Members in Adult Reconstruction
What the Researchers Tested
This cross-sectional comparative analysis utilized 55 multiple-choice questions from the American Academy of Orthopaedic Surgeons (AAOS) ResStudy question bank, specifically targeting adult reconstruction topics. The questions were carefully selected to represent varying levels of difficulty as defined by AAOS, and categorized by anatomic region (hip vs. knee) and core clinical concepts: clinical presentation, prognosis, and management. Seven prominent AI chatbots were tested: ChatGPT-3.5, ChatGPT-4, ChatGPT-4o, Gemini, Gemini Advanced, Claude, and Co-Pilot. The research methodology involved systematically querying each chatbot with the selected questions and meticulously recording their responses. Key metrics evaluated included diagnostic accuracy (percentage of correct answers), response time in seconds, and the quality of generated citations (existence and clinical relevance). Statistical analyses, including chi-square tests, t-tests, Pearson correlation, one-way ANOVA, and Kruskal-Wallis testing, were employed to discern significant differences and relationships (p<0.05) across chatbot performances and question characteristics. This rigorous evaluation provides a robust benchmark for AI capabilities in a specialized medical education domain.
What the Study Found
Overall chatbot accuracy across all models and questions was 67.5%.
GPT-4o achieved the highest accuracy at 80%, outperforming the average AAOS member score of 75%.
Co-Pilot ranked second in accuracy at 70.9%.
Accuracy varied significantly by clinical concept: highest for Clinical Presentation (78.6%) and lowest for Prognosis (63.1%).
Question difficulty inversely correlated with accuracy, with performance dropping from 84.7% for very easy questions to 45.4% for difficult questions.
Average response time was 3.6 seconds, with no significant correlation between speed and accuracy.
Among chatbots providing citations, Co-Pilot demonstrated 100% citation existence and relevance.
Why This Matters to Clinical Practice
The integration of AI chatbots into medical education holds substantial promise for enhancing learning efficacy and accessibility, yet their reliability for complex clinical reasoning has remained a critical concern for medical educators and practicing clinicians. This study provides crucial evidence regarding the current capabilities and limitations of leading AI models in a specialized field like adult reconstruction. Identifying that some AI models, particularly GPT-4o, can outperform human specialists on certain assessment types underscores the potential for AI to serve as a powerful supplementary tool, offering rapid access to information and reinforcing descriptive knowledge. However, the observed struggle of AI in areas requiring applied reasoning, such as prognosis and management, highlights a significant gap. For orthopedic surgeons and residents, accurate prognosis and optimal management strategies are paramount for patient safety and clinical outcomes. Relying on AI for these complex tasks without human oversight could lead to suboptimal decision-making. Therefore, these findings are vital for guiding the judicious adoption of AI in clinical training, ensuring that its application complements human expertise rather than replacing it in high-stakes reasoning domains, ultimately impacting patient care through improved educational support.
Clinical & Workflow Takeaways
For orthopedic program directors and educators, these findings suggest that AI chatbots, especially high-performing models like GPT-4o, can be effectively integrated as supplementary learning resources for reinforcing foundational and descriptive knowledge in adult reconstruction. They are particularly useful for quick information retrieval on clinical presentations. However, clinicians and trainees must exercise caution and maintain critical oversight when using AI for questions involving complex applied reasoning, such as determining prognosis or optimal surgical management. It is crucial to emphasize that current AI tools should not replace comprehensive learning resources or expert clinical judgment in these critical areas. Future curriculum development might consider incorporating AI tools while explicitly teaching residents how to evaluate AI-generated responses for reliability and clinical appropriateness, particularly regarding the nuanced aspects of patient care.
Limitations and What Remains Uncertain
The study's limitations include its reliance on a single question bank (AAOS ResStudy) and a specific specialty (adult reconstruction), which may limit the generalizability of findings to other medical disciplines or question formats. The inherent nature of multiple-choice questions, even those designed for clinical relevance, may not fully capture the complexity of real-world clinical decision-making, which often involves open-ended problem-solving and nuanced patient interactions. Furthermore, the rapid evolution of AI models means that the performance of the tested chatbots could improve significantly even shortly after publication, making the 'state-of-the-art' a moving target. The evaluation of citation quality, while important, was limited to existence and relevance, without a deeper dive into the veracity or clinical guidelines adherence of the cited sources themselves. The cross-sectional design also prevents analysis of longitudinal performance trends or learning curves of the AI models.
Explore the Work Behind Clinical AI
MedXchange Research Fellowship
Publish Clinical AI Research With Us
Our 10-week fellowship mentors physicians and researchers to build foundation models, analyze multimodal health datasets, and co-author peer-reviewed clinical studies.
Related Clinical AI Stories
AI in Precision Psychiatry: Navigating Biomarker Discovery from Concept to Clinic
The field of psychiatric biomarker discovery has long been hampered by challenges including suboptimal phenotypic characterization and limited cohort sizes. Recent advancements in artificial intelligence (AI), particularly large language models (LLMs) and self-supervised learning, are poised to revolutionize this landscape by transforming vast amounts of unstructured clinical text into quantifiable data and extracting insights from routinely collected, unlabeled psychiatric signals. This review highlights AI's role in the early stages of biomarker identification, from molecular interpretation to candidate generation. While AI demonstrates significant potential in identifying novel psychiatric biomarkers, a critical gap remains between computational discovery and clinical utility. The review emphasizes an inherent asymmetry: AI can rapidly generate biomarker candidates, but the rigorous, costly process of clinical validation for real-world application remains largely unaddressed by AI itself. The authors propose a structured, six-stage framework to bridge this gap, delineating the journey from intended clinical use and measurement validity to model evaluation, comparative utility, and ultimately, monitored deployment. This framework clarifies where AI can accelerate discovery and where traditional clinical validation is indispensable.
AI and Digital Technologies Transforming Multiple Sclerosis Neurorehabilitation
Recent advancements in neurorehabilitation for Multiple Sclerosis (MS) are shifting towards earlier, personalized, and technology-supported interventions. While pharmacological treatments have evolved, a significant number of individuals with MS (pwMS) continue to face complex symptom burdens, functional limitations, and reduced quality of life. This review emphasizes the integration of routine, multidimensional screening that extends beyond symptom severity to include functional status, participation restrictions, and social determinants of health (SDoH). The embrace of digital health technologies, such as wearables, remote monitoring, and AI-assisted assessments, offers new avenues for more ecologically valid and accessible evaluation of pwMS. The emerging paradigm posits neurorehabilitation as a fundamental component of comprehensive MS care, advocated for initiation early in the disease course rather than as a late-stage intervention. Exercise programs, cognitive rehabilitation, psychological therapies, and vocational rehabilitation are showing benefits across physical, cognitive, emotional, and fatigue domains, ultimately improving quality of life. Telerehabilitation and technology-supported approaches like virtual reality (VR), exergaming, and neuromodulation are proving instrumental in enhancing access to care and improving patient outcomes, despite ongoing needs for further research into their optimal application and widespread implementation.
FAHR-Face: Clinical Foundation AI Models Extract Multi-System Health Biomarkers from Facial Photographs
Recent advances in deep learning have demonstrated that human facial phenotypes encapsulate intricate physiological, metabolic, and biological aging signals. In a landmark study published in The Lancet Digital Health, investigators led by researchers from Mass General Brigham and Harvard Medical School introduced FAHR-Face (Foundation Artificial Intelligence Models for Health Recognition by Use of Face Photographs), a self-supervised and multitask foundation architecture designed to extract systemic clinical biomarkers directly from standard 2D facial photography. By pretraining visual transformers across large-scale facial datasets linked with deep electronic health records, the investigators developed a generalizable computational platform capable of phenotyping across multiple organ systems without reliance on specialized imaging modalities. The study evaluated FAHR-Face across diverse multi-institutional cohorts to benchmark its capacity for predicting chronological age gaps, metabolic dysregulation, cardiorespiratory endpoints, and all-cause mortality. The architecture demonstrated robust zero-shot and few-shot transfer learning, outperforming conventional single-task convolutional networks in identifying latent systemic pathology. This investigation shifts the paradigm of facial biometric analysis from cosmetic or genetic syndromic dysmorphology screening to systemic, longitudinal health risk stratification and passive screening in outpatient and primary care environments.